Table 3 Unadjusted secondary outcomes by intervention periods
Intervention (N = 174) | Non-intervention (N = 194) | Total (N = 368) | P-Value | OR (95% CI) | |
|---|---|---|---|---|---|
Penicillin allergy delabelling | |||||
Patients delabeled 48 h from admission | 23 (13.2%) | 2 (1.0%) | 25 (6.8%) | < 0.001 | 14.63 (3.39–62.99) |
Patient delabeled 6 months from admission | 26 (14.9%) | 3 (1.5%) | 29 (7.9%) | < 0.001 | 11.18 (3.32–37.67) |
Prescribing amongst all patients | |||||
Beta-lactam use during admission | 63 (36.2%) | 64(34.0%) | 129(35.1%) | 0.91 | 1.10 (0.72–1.69) |
Beta-lactam use 6 months from admission | 28 (16.1%) | 15 (7.7%) | 43 (11.7%) | 0.04 | 2.29 (1.18–4.45) |
Non Beta-lactam use during admission | 76 (43.7%) | 65 (34.5%) | 143 (38.9%) | 0.2 | 1.47 (0.96–2.24) |
Non Beta-lactam use 6 months from admission | 24 (14.4%) | 29 (14.9%) | 54 (14.7%) | 0.99 | 0.95 (0.53–1.70) |
Prescribing amongst those who received at least one antibiotic | |||||
Beta-lactam use during admission | 63 (55.75%) | 64 (57.1%) | 127 (56.4%) | 0.98 | 1.49 (0.86–2.56) |
Non Beta-lactam use during admission | 76 (67.3%) | 65 (58.0%) | 141 (62.7%) | 0.36 | 0.95 (0.56–1.60) |
Non Beta-lactam use 6 months from admission | 24 (52.2%) | 29 (72.5%) | 53 (61.6%) | 0.15 | 0.41 (0.17–1.02) |
C. difficile infection 3 months from admission | 2 (1.1%) | 4 (2.1%) | 6 (1.6%) | 0.79 | 0.55 (0.10–3.05) |
Mean length of stay (SD) | 6.93 (8.49) | 7.74 (10.8) | 7.35 (9.77) | 0.42 | NA |